Guidance Snapshots are a communication tool that provide highlights from the document using visuals and plain language. This pilot program is intended to increase awareness for FDA guidance documents to support the efficient application of the documents’ recommendations.
Similar Posts
Contra Reumas may be harmful due to hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use Contra Reumas, a product promoted and sold for joint pain on various websites, including naturistarex.com, and possibly in some retail stores.FDA Grand Rounds – Anti-biofilm Technologies for Enhancing the Safety of Medical Device Surfaces – 05/29/2025
Anti-biofilm Technologies for Enhancing the Safety of Medical Device Surfaces, May 29, 2025.Early Alert: TactiFlex Ablation Catheter Issue from Abbott
Abbott has issued new instructions on removing TactiFlex Ablation Catheter, Sensor Enabled from its packaging due to tip detachment issuesOngoing | Non-malignant Hematological, Neurological, and Other Disorder Indications Accelerated Approvals
Drug and Biologic Accelerated Approvals Based on a Surrogate EndpointDiagnostic Intravascular Catheter Recall: Conavi Removes Novasight Hybrid Catheters
This communication is part of the Communications Pilot to Enhance the Medical Device Recall ProgramQ&A on CGMP Requirements
Pharmaceutical Quality/Manufacturing Standards (CGMP)